These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8826474)

  • 1. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis in known fragile X carriers.
    Maddalena A; Hicks BD; Spence WC; Levinson G; Howard-Peebles PN
    Am J Med Genet; 1994 Jul; 51(4):490-6. PubMed ID: 7943026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X mental retardation syndrome: DNA diagnosis and carrier detection in New Zealand families.
    Neville L; Cochrane J; Fitzgerald P; Kennedy M
    N Z Med J; 1995 Oct; 108(1009):404-6. PubMed ID: 7478333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular fragile X screening in normal populations.
    Spence WC; Black SH; Fallon L; Maddalena A; Cummings E; Menapace-Drew G; Bick DP; Levinson G; Schulman JD; Howard-Peebles PN
    Am J Med Genet; 1996 Jul; 64(1):181-3. PubMed ID: 8826471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to antenatal screening for Fragile X syndrome.
    Wald NJ; Morris JK
    Prenat Diagn; 2003 Apr; 23(4):345-51. PubMed ID: 12673644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRAXA locus in fragile X diagnosis: family studies, prenatal diagnosis, and diagnosis of sporadic cases of mental retardation.
    von Koskull H; Gahmberg N; Salonen R; Salo A; Peippo M
    Am J Med Genet; 1994 Jul; 51(4):486-9. PubMed ID: 7943025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
    Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
    Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
    Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
    Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for reliable prenatal detection of normal male carriers of the fragile X syndrome.
    Halley D; Van Den Ouweland A; Deelen W; Verma I; Oostra B
    Am J Med Genet; 1994 Jul; 51(4):471-3. PubMed ID: 7943022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct mutation analysis of 495 patients for fragile X carrier status/proband diagnosis.
    Kaplan G; Kung M; McClure M; Cronister A
    Am J Med Genet; 1994 Jul; 51(4):501-2. PubMed ID: 7943028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular screening for fragile X syndrome in Thailand.
    Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation.
    Rousseau F; Heitz D; Biancalana V; Blumenfeld S; Kretz C; Boué J; Tommerup N; Van Der Hagen C; DeLozier-Blanchet C; Croquette MF
    N Engl J Med; 1991 Dec; 325(24):1673-81. PubMed ID: 1944467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of small FRAXA premutations.
    Francis D; Burgess T; Mitchell J; Slater H
    Mol Diagn; 2000 Sep; 5(3):221-5. PubMed ID: 11070156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.